Healthcare Trends

Operational AI & Technology Enablement briefings for the Healthcare Industry Is Almost Here ...


  • Intelligence
  • Operations
  • Workforce
  • Governance
  • Resources
  • Services

Contact us: info@salusatlas.com

Español | Deutsch

Healthcare in the Age of Artificial Intelligence

Between Strategic Opportunity and Political Responsibility

Artificial intelligence (AI) is transforming nearly every area of the economy and daily life, and healthcare is facing profound change. The crucial question is no longer whether AI will play a role, but how much strategy and responsibility will go into integrating it.

AI Is More Than Another Step in Digitization

The digitization of recent years had a clear goal: put processes online, simplify administration, and increase efficiency. AI marks a new stage. It is about intelligent systems that:

  • support medical decisions,
  • identify risks early,
  • manage resources more efficiently,
  • accelerate research, and
  • automate administrative tasks.
AI is thus becoming a strategic core technology with an infrastructural character, though not like a classic utility such as electricity or the internet, but as a data-driven decision architecture.

Where AI Is Already Making an Impact

Diagnostic imaging. By late June 2026, the FDA’s list named 1,614 authorized AI-enabled medical devices, though the agency itself stresses that the list is not comprehensive. The focus is clearly on radiology, which accounts for 76 percent of entries.

Clinical documentation. So-called ambient scribes, which listen to patient consultations and draft clinical notes, are currently the most visible use of generative AI. According to a study in the American Journal of Managed Care, nearly two-thirds of US hospitals using Epic systems had adopted such tools by June 2025. The real-world effect is more sober than the marketing suggests: a JAMA study compared over 1,800 clinicians using scribes with 6,770 controls and found only modest documentation time savings. Work outside regular hours barely changed.

Agentic AI in administration. The next wave consists of systems that carry out entire workflows on their own. They are landing first where tasks are repetitive and rule-based, such as scheduling, prior authorization, and billing, not diagnosis. In a Deloitte survey, over 80 percent of healthcare executives expect meaningful value.

What matters: AI generally does not replace doctors, nurses, or specialists. It automates partial processes, analyzes large amounts of data faster than humans, and changes job profiles. Responsibility ultimately remains with people.

Strategic Management Instead of Technological Euphoria

Many countries have adopted national AI strategies or comprehensive digital health programs. But strategy documents alone do not change a system. What counts is:

  • clear governance structures,
  • regulatory certainty,
  • investment in data quality and interoperability,
  • staff qualification,
  • transparent performance measurement.
Without these foundations, AI remains a pilot project rather than a transformative force.

The Regulatory Framework in Europe

Two sets of rules shape implementation.

EU AI Act. Deadlines have been pushed back: the Council gave final approval to the “Digital Omnibus on AI” on 29 June 2026. For AI embedded in medical devices, the high-risk obligations now apply from 2 August 2028; for standalone high-risk systems, from 2 December 2027. The transparency obligations under Article 50, however, have not been delayed. Critics note that the Omnibus shortens timelines but not the bureaucratic burden.

European Health Data Space (EHDS).Regulation (EU) 2025/327 has been in force since 26 March 2025. Implementation is phased and spans roughly ten years. This is central for AI: without accessible, standardized health data, there is no basis for validated models.

The Real Challenges

Despite all the momentum, the risks must not be ignored:

  • algorithmic bias,
  • insufficiently validated models,
  • data protection and cyber risks,
  • dependence on large technology providers,
  • high implementation costs,
  • limited evidence on long-term cost effects.
The case of ambient scribes shows that adoption can outrun evidence. Healthcare systems operate within a delicate ethical framework. Efficiency gains must not come at the expense of transparency, safety, or trust.

What Is Decisive Now

The strategic question is not whether AI will be used, but whether it will

  • serve selectively for process optimization or
  • be systematically integrated into care delivery and decision-making structures.
Sustainable integration requires:

  • reform of education and training,
  • new interdisciplinary skill profiles,
  • adapted regulatory frameworks,
  • clear responsibilities,
  • long-term investment strategies.
AI is not an end in itself. It is a tool. Its effectiveness depends on governance, quality control, and political leadership.

Outlook: Hybrid Architectures

In the long run, hybrid AI architectures are likely to take hold. Classical high-performance computers and AI systems could be complemented by quantum computing, for example for very large, complex datasets in genomics, drug development, and personalized medicine. Neuromorphic systems, modeled on biological neural networks, are also being explored, with potential for energy-efficient, adaptive robotics in rehabilitation and nursing. Both technologies remain largely in research or early development; their clinical benefit has not been demonstrated.

AI can identify patterns in health data that elude the intuitive judgment of professionals (see Frontiers in Digital Health, 2025). However, its clinical relevance must be verified through evidence-based validation, such as prospective studies of consecutive patient cohorts, before it is used in practice.

Conclusion

Artificial intelligence is neither a panacea nor a passing fad. Whether it becomes a strategic advantage depends not on individual applications, but on a healthcare system’s ability to reconcile innovation, regulation, and responsibility. The future of medicine will not be merely digital. It will be data-driven, networked, and, at best, more intelligent.

References: Casrai/K&L Gates/Pure Global (AI Omnibus), BCPlatforms/HIMSS (EHDS), AJMC 2026, JAMA 2026 (Rotenstein et al.), HIT Consultant, Deloitte 2026 Outlook, Complizen/AI2Work (FDA-Liste), Frontiers in Digital Health 2025.